About Loyal
Loyal is a clinical-stage veterinary medicine company that develops drugs intended to extend the healthspan and lifespan of dogs. It develops longevity drugs for dogs, including senior and large-breed dogs. Loyal makes money by selling pharmaceutical therapies for dogs.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $100,000,000 · Series-B+
businesswire.com
- Capital Raise
Raised $22,000,000 · Series-B+
finsmes.com
- Capital Raise
Raised $45,000,000 · Series-B+
- Milestone
X account created (@loyalfordogs)
4.4K followers
- Milestone
Website domain registered
loyal.com
Investors & Backers
Funding History
Founders & Leadership
Press Coverage & Sources
businesswire.com/news/home/20260211301175/en/Loyal-Raises-%24100M-Series-C-Led-by-age1-to-Advance-the-First-Canine-Longevity-Drug
startups.gallery/companies/loyal-dogs
finsmes.com/2025/02/loyal-closes-22m-series-b-2-funding.html
finsmes.com/2024/03/loyal-raises-45m-in-series-b-financing.html
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com